Yum! Brands, Inc. (NYSE: YUM) has recently been named one of Black Enterprise Magazine’s “40 Best Companies for Diversity” for its comprehensive results across key diversity measures for the sixth consecutive year.
Black Enterprise’s sixth annual list of the best companies for diversity is featured in the July 2010 edition. The Magazine evaluated diversity programs, consulted with diversity experts and surveyed over 1,000 of the country’s largest public companies and 50 leading global companies with significant U.S. operations. The Magazine made its selection based on the number of African–Americans and members of other ethnic minority groups in four categories including supplier diversity, senior management, Board of Directors and total employee base. Black Enterprise reported that supplier diversity and total employee base are two areas in which Yum! Brands is particularly strong.
YUM! Brands, Inc., together with its subsidiaries, operates as a quick service restaurant company worldwide. The company develops, operates, franchises, and licenses a system of restaurants, which prepare, package, and sell various food items. Its restaurants specialize in chicken, pizza, Mexican-style food, and quick-service seafood categories. As of December 26, 2009, it operated approximately 37,000 restaurants in 110 countries and territories under the KFC, Pizza Hut, Taco Bell, Long John Silvers, and A&W All-American Food Restaurants brands.
Last: $40.53
Change: +0.26 (+0.65%)
For more information about this company please visit http://www.yum.com
Novelos Therapeutics, Inc. (OTC BB: NVLT.OB) reported today positive results in a Phase 2 trial of NOV-002 in combination with neoadjuvant chemotherapy treatment in patients with stage IIB-IIIC HER-2/neu negative invasive breast cancer, conducted by the Braman Family Breast Cancer Institute at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine. Alberto Montero, MD, Assistant Professor of Medicine at the Miller School and medical oncologist at Sylvester, is the Principal Investigator.
This Phase 2 open-label, single-arm, Simon 2-Stage trial was designed to determine if preoperative administration of NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel (AC-T) results in at least a doubling in the rate of pathologic complete response (pCR) compared to a historical control. For NOV-002 to be declared active at the end of the trial, a minimum of 12 patients must achieve a pCR. This criterion of 12 pCRs has been met prior to all patients completing the trial. Patient enrollment continues and some patients are still in the NOV-002 treatment stage. Trial results have been submitted for presentation to the AACR Breast Cancer Symposium taking place in San Antonio, TX, in December 2010.
Novelos Therapeutics, Inc. is a biopharmaceutical company commercializing oxidized glutathione-
Last: $0.1330
Change: +0.0180 (+15.65%)
For more information about this company please visit http://www.novelos.com
Dr Pepper Snapple Group, Inc. (NYSE: DPS) continues its 125th Anniversary celebration with the release of Dr Pepper made with real sugar in six collectible cans, inspired by the beloved brand’s rich history. Consumers can enjoy the 23 flavors of Dr Pepper in this new packaging beginning in early July through early September.
The anniversary cans feature legacy artwork and popular advertising slogans such as “I’m a Pepper” and “10, 2 and 4.” In addition, 12-pack cases highlight key moments from the brand’s history from its origin at Morrison’s Old Corner Drug Store in Waco, TX, in 1885, and its introduction at the 1904 World’s Fair, to the widely popular “I’m a Pepper” advertisements first released in 1977.
Dr Pepper, a brand of Dr Pepper Snapple Group is the oldest major soft drink in the United States. Since 1885, the 23 flavors of Dr Pepper have earned legions of fans that enjoy its unique, refreshing taste. The brand is available in Regular, Diet, Caffeine Free and Cherry varieties. DPS is a leading producer of flavored soft drinks, marketing Dr Pepper and 50-plus other beverage brands across North America and the Caribbean.
Last: $38.54
Change: +0.00 (0.01%)
For more information about this company please visit www.drpeppersnapple.com
CRWESelect, a stock highlight publication is pleased to alert investors of stocks on the move.
Sign Up for our Free Stock Newsletter at http://www.crweselect.com/
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment (read more) Rule 17B requires disclosure of payment for investor relations.
The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings, Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone.
